{"id":166869,"date":"2010-01-11T17:26:09","date_gmt":"2010-01-11T22:26:09","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=58103"},"modified":"2010-01-11T17:26:09","modified_gmt":"2010-01-11T22:26:09","slug":"bind-hires-new-ceo-raises-11m","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/166869","title":{"rendered":"BIND Hires New CEO, Raises $11M"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Life-Sciences\/\">Life Sciences<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/deals\/\">deals<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/ceo\/\">ceo<\/a><\/div>\n<p>\t\t<strong>Ryan McBride wrote:<\/strong><\/p>\n<p>BIND Biosciences, a Cambridge, MA-based developer of nanoparticle drugs, <a href=\"http:\/\/www.businesswire.com\/news\/home\/20100111006767\/en\/BIND-Biosciences-Appoints-Scott-Minick-President-CEO\">says<\/a> today that it has appointed Scott Minick as its president and CEO. Minick was previously a managing director of ARCH Venture Partners, a major investor in BIND. The company also told Mass High Tech that it has raised $11 million in a Series C round of financing, bringing its total venture financing raised to $29.5 million.<\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/boston\/2010\/01\/11\/bind-hires-new-ceo-raises-11m\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20BIND%20Hires%20New%20CEO,%20Raises%20$11M%20http:\/\/xconomy.com\/?p=58103\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/boston\/2010\/01\/11\/bind-hires-new-ceo-raises-11m\/&#038;t=BIND%20Hires%20New%20CEO,%20Raises%20$11M\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/boston\/2010\/01\/11\/bind-hires-new-ceo-raises-11m\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=BIND+Hires+New+CEO%2C+Raises+%2411M&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fboston%2F2010%2F01%2F11%2Fbind-hires-new-ceo-raises-11m%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=8f7134043550bb354efe3cc66afe40f9&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=8f7134043550bb354efe3cc66afe40f9&#038;p=1\"\/><\/a><br \/>\n<img loading=\"lazy\" decoding=\"async\" alt=\"\" height=\"0\" width=\"0\" border=\"0\" style=\"display:none\" src=\"http:\/\/a.rfihub.com\/eus.gif?eui=2218\"\/><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/d9fCTETvFUfziZCkJvnpT24NvJ8\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/d9fCTETvFUfziZCkJvnpT24NvJ8\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/d9fCTETvFUfziZCkJvnpT24NvJ8\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/d9fCTETvFUfziZCkJvnpT24NvJ8\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/PA0VspkztAQ\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Life Sciences, deals, ceo Ryan McBride wrote: BIND Biosciences, a Cambridge, MA-based developer of nanoparticle drugs, says today that it has appointed Scott Minick as its president and CEO. Minick was previously a managing director of ARCH Venture Partners, a major investor in BIND. The company also told Mass High Tech that it has raised [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-166869","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/166869","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=166869"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/166869\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=166869"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=166869"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=166869"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}